Optimal Design and Patient Selection for Interventional Trials Using Radiogenomic Biomarkers: A REQUITE and Radiogenomics Consortium Statement

Radiotherapy and Oncology - Netherlands
doi 10.1016/j.radonc.2016.11.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Consensus Statement From the International Stereotactic Body Radiotherapy Consortium for Head and Neck Carcinoma—Patient Selection and Pre- And Post-Stereotactic Body Radiation Therapy Evaluation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Evaluation of Biomarkers for Treatment Selection Using Individual Participant Data From Multiple Clinical Trials

Statistics in Medicine
EpidemiologyStatisticsProbability
2018English

Optimal Patient Selection for Stereotactic Body Radiotherapy

The Lancet Oncology
Oncology
2019English

Patient Dose Audit Using Interventional and Conventional Radiograph

Journal of Medical Diagnostic Methods
2017English

A Wild Bootstrap Approach for the Selection of Biomarkers in Early Diagnostic Trials

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2015English

Lung Transplantation: A Review of the Optimal Strategies for Referral and Patient Selection

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2019English

Optimal Design for Experiments With Potentially Failing Trials

MODA4 — Advances in Model-Oriented Data Analysis
1995English

Design and Estimation in Clinical Trials With Subpopulation Selection

Statistics in Medicine
EpidemiologyStatisticsProbability
2018English

The AIDS Malignancy Clinical Trials Consortium (AMC) Patient Navigator (PN) Initiative

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy